Current understanding and management of medullary thyroid cancer. - Wikidata - awgldk - TriplyDB

Current understanding and management of medullary thyroid cancer.

Current understanding and management of medullary thyroid cancer.

http://www.wikidata.org/entity/Q37247181

about

Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.Evaluation and management of the pediatric thyroid nodule Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.Herpes and polyoma family viruses in thyroid cancer.Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography Safety and efficacy of dulaglutide, a once weekly GLP-1 receptor agonist, for the management of type 2 diabetes.Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.Medullary thyroid carcinoma: a review on ethical considerations in treatment of children.Concurrent Medullary, Papillary, and Follicular Thyroid Carcinomas and Simultaneous Cushing's Syndrome.Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?The Role of Core Needle Biopsy and Its Impact on Surgical Management in Patients with Medullary Thyroid Cancer: Clinical Experience at 3 Medical Institutions.Educational Case: Endocrine Neoplasm: Medullary Thyroid Carcinoma.

P2860

Q34739831-465986B9-D566-4AC6-BD09-7F1E7B023D4C Q34959924-F23BDBB8-5E4B-4BBE-86C1-7F2241270F8A Q35523958-02C99EAB-E596-4437-898A-A81346976EFA Q35963760-B8A2B0C4-E5EB-49B1-AF6A-0B4C2EF02005 Q36640448-9B55EB8D-EE3C-4F4C-8F6B-42558C65BEB4 Q37009001-DC44F426-4CF8-4F6F-9B24-F1C0AA996120 Q37328939-783A08E4-F626-47EA-ADC5-D50EFAE58A98 Q37633558-4E0B8687-E9AE-427A-BA09-400FC3F00F85 Q37729290-09DDDB72-6858-4F86-92C3-01A3927EE110 Q38248262-9DABC243-28BB-448E-A254-064798D2B703 Q38270204-98888494-D24F-41D9-8A1B-982458AB2FEB Q38671439-FBF28700-9B96-4C24-92EF-A6EC6DB0A348 Q38773702-5437A2DE-4582-411C-BEAC-14DB174A09F9 Q39008775-9F118521-AAA6-4641-992D-DEB946AE68AF Q41712392-396E632C-38E6-479E-9132-D0264208ED44 Q42378482-6E25EBED-4212-4E74-A1B2-A99E210A8CBC Q50873143-E3EF02EE-BDF1-4BE0-9D45-9B045DE51390 Q52985771-4B800CC6-BF7F-4613-A006-303FEB1D335F Q53087643-8649C0E1-C33F-4337-B9DB-63ECC14B70B8 Q53523029-72BC602D-A861-4D7D-A8F3-C5B998B8F631 Q55491526-CAB0763B-9D5F-4876-AAB9-A5D49B025833

P2860

Current understanding and management of medullary thyroid cancer.

http://www.wikidata.org/entity/Q37247181

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current understanding and management of medullary thyroid cancer.

@en

Current understanding and management of medullary thyroid cancer.

@nl

type

label

Current understanding and management of medullary thyroid cancer.

@en

Current understanding and management of medullary thyroid cancer.

@nl

prefLabel

Current understanding and management of medullary thyroid cancer.

@en

Current understanding and management of medullary thyroid cancer.

@nl

P1433

Q37247181-2A993796-F46F-46A1-B3F2-E56C9E8F8FB6

P1476

Q37247181-9A221A69-685E-440A-8DB4-ECDCC0568676

P2093

Q37247181-4371F294-B309-43D9-89E9-4FD41FED7788

Q37247181-49CE876A-B20B-4A6C-8DE6-A4FFDA5BCACE

Q37247181-E235BF01-218E-474C-92B8-0139E44EA966

P2860

Q37247181-04887823-B15C-4F5C-9CCC-353C35538E55

Q37247181-07113A64-6C4E-4763-981A-AE343D7271D5

Q37247181-0D02E334-90FC-40D7-A698-726E2485AAAA

Q37247181-0D7495D1-3581-4A38-B39C-6E6A5810B32C

Q37247181-0D9C6094-50DE-4114-B425-8B642878B3DA

Q37247181-10A65D8D-0BA7-40B7-A7B9-BBB92B3777D8

Q37247181-11340F9C-F54C-48B3-89D1-FB7DF35AD08C

Q37247181-250C7603-7176-4564-85A8-0763110140E3

Q37247181-2D3D5623-EA5E-4FE2-BA2B-C203579FCA99

Q37247181-30169E58-C5F2-4BED-A6F4-6A70083ABB66

P304

Q37247181-965398B6-5BF3-465A-B5B2-2BAA649782BE

P31

Q37247181-DD8A2736-551C-4377-8056-BE809959912A

P356

Q37247181-B98EF2CF-204C-4549-BFEB-28AF5F1018BD

P433

Q37247181-C90852D4-C569-46D6-8FE9-769EC67D6AC1

P478

Q37247181-865331DF-44C3-4FB5-8E47-B377417D3E9F

P577

Q37247181-B1C737C4-D180-43DD-9CFA-031115F9BA59

P698

Q37247181-2F3FF5E2-6E58-4C88-8625-782D1A29D219

P932

Q37247181-DE4F7022-D786-4368-BD00-495C0A228F1B

P356

THEONCOLOGIST.2013-0053

P1433

P1476

Current understanding and management of medullary thyroid cancer.

@en

P2093

Herbert Chen

http://www.w3.org/2001/XMLSchema#string

Madhuchhanda Roy

http://www.w3.org/2001/XMLSchema#string

Rebecca S Sippel

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

Multiple endocrine neoplasia type 2: an overview

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.

Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.

Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.

P304

1093-1100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2013-0053

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24037980

http://www.w3.org/2001/XMLSchema#string

P932

3805151

http://www.w3.org/2001/XMLSchema#string